RecruitingNCT06212947
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Sponsor
BioMarin Pharmaceutical
Enrollment
400 participants
Start Date
Nov 27, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Eligibility
Max Age: 15 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with hypochondroplasia. The study is currently recruiting participants at 43 locations. People eligible for this study include up to age 15 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(43)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06212947
Related Trials
Prospective Clinical Assessment Study in Children With Hypochondroplasia
NCT0641097625 locations
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
NCT0712626226 locations
Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia
NCT073889661 location
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
NCT053280501 location